Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (40)
Marlaina R. Stocco & Rachel F. Tyndale. 2022. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary. Pharmacology and Toxicology of Cytochrome P450 – 60th Anniversary
73
106
.
Kirsten M. Pondman, Ron H.N. van Schaik & Jan van der Weide. (2018) Accurate determination of the CYP2D6 (*1/*4)xN genotype by quantitative PCR. Drug Metabolism and Personalized Therapy 33:1, pages 33-39.
Crossref
Crossref
Ling-ling Zhu, Meng Chen & Quan Zhou. (2015) Is Promethazine 6.25 mg Intravenous Dose Really Ideal to Treat Postoperative Nausea and Vomiting?. Journal of PeriAnesthesia Nursing 30:4, pages 269-271.
Crossref
Crossref
Ann K. Daly. 2015. Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer. Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer
85
111
.
Pierre BaumannJosé AG AgúndezElena García-Martin. 2014. CYP2D6: Genetics, Pharmacology and Clinical Relevance. CYP2D6: Genetics, Pharmacology and Clinical Relevance
118
133
.
SARAH C. CAMPBELL & MICHAEL G. SPIGARELLI. (2013) Pharmacology and Pharmacogenomics of Neurological Medications Used in Pregnancy. Clinical Obstetrics and Gynecology 56:2, pages 305-316.
Crossref
Crossref
Tjorvi E. Perry & Charles D. Collard. 2013. Pharmacology and Physiology for Anesthesia. Pharmacology and Physiology for Anesthesia
58
69
.
Olivier Bouché & Pierre Laurent-PuigV. Le Morvan & J. Robert. 2013. Médecine personnalisée en cancérologie digestive. Médecine personnalisée en cancérologie digestive
59
74
.
Eric R. Fedyk. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
71
90
.
Su-Jun Lee, Sang Seop Lee, Hyun-Ju Jung, Ho-Sook Kim, Soo-Jin Park, Chang-Woo Yeo & Jae-Gook Shin. (2009)
Discovery of Novel Functional Variants and Extensive Evaluation of
CYP2D6
Genetic Polymorphisms in Koreans
. Drug Metabolism and Disposition 37:7, pages 1464-1470.
Crossref
Crossref
R. Searle & P.M. Hopkins. (2009) Pharmacogenomic variability and anaesthesia. British Journal of Anaesthesia 103:1, pages 14-25.
Crossref
Crossref
Jose de Leon, Margaret T. Susce, Maria Johnson, Mike Hardin, Lorraine Maw, Alison Shao, Antonette C.P. Allen, Francis A. Chiafari, Grantland Hillman & D. Michele Nikoloff. (2014)
DNA Microarray Technology in the Clinical Environment:
The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping
. CNS Spectrums 14:1, pages 19-35.
Crossref
Crossref
Ulrich M. Zanger, Miia Turpeinen, Kathrin Klein & Matthias Schwab. (2008) Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Analytical and Bioanalytical Chemistry 392:6, pages 1093-1108.
Crossref
Crossref
Rebecca L RobertsRichard B Gearry, Martin A Kennedy & Murray L Barclay. (2008) Beyond TPMT: genetic influences on thiopurine drug responses in inflammatory bowel disease. Personalized Medicine 5:3, pages 233-248.
Crossref
Crossref
Ann K. Daly. 2008. Pharmacogenomics and Personalized Medicine. Pharmacogenomics and Personalized Medicine
109
120
.
Claudia Toscano, Kathrin Klein, Julia Blievernicht, Elke Schaeffeler, Tanja Saussele, Sebastian Raimundo, Michel Eichelbaum, Matthias Schwab & Ulrich M. Zanger. (2006) Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events. Pharmacogenetics and Genomics 16:10, pages 755-766.
Crossref
Crossref
Jatinder K. Lamba, Xin Chen, Lu-Bin Lan, Jin Woo Kim, Xin Wei Wang, Mary V. Relling, Yasuda Kazuto, Paul B. Watkins, Stephen Strom, Daxi Sun, John D. Schuetz & Erin G. Schuetz. (2006) Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans. Pharmacogenetics and Genomics 16:6, pages 415-427.
Crossref
Crossref
Stephen Wooding & Lynn B. Jorde. (2006) Duplication and divergence in humans and chimpanzees. BioEssays 28:4, pages 335-338.
Crossref
Crossref
Paul R. Casner. (2005) The Effect of CYP2D6 Polymorphisms on Dextromethorphan Metabolism in Mexican Americans. The Journal of Clinical Pharmacology 45:11, pages 1230-1235.
Crossref
Crossref
Lin Wu, P. Mickey Williams & Walter H. Koch. (2005) Clinical applications of microarray-based diagnostic tests. BioTechniques 39:4S, pages S557-S582.
Crossref
Crossref
Janelle M. Hoskins, Sharon Marsh & Howard L. McLeod. (2005) COMMENT ON “A FRAMESHIFT MUTATION AND ALTERNATE SPLICING IN HUMAN BRAIN GENERATE A FUNCTIONAL FORM OF THE PSEUDOGENE CYTOCHROME P4502D7 THAT DEMETHYLATES CODEINE TO MORPHINE”. Drug Metabolism and Disposition 33:10, pages 1564-1565.
Crossref
Crossref
Jörg Zukunft, Thomas Lang, Tanja Richter, Karen I. Hirsch-Ernst, Andreas K. Nussler, Kathrin Klein, Matthias Schwab, Michel Eichelbaum & Ulrich M. Zanger. (2005)
A Natural
CYP2B6
TATA Box Polymorphism (–82T→ C) Leading to Enhanced Transcription and Relocation of the Transcriptional Start Site
. Molecular Pharmacology 67:5, pages 1772-1782.
Crossref
Crossref
Stephen N. Palmer, N Martin Giesecke, Simon C. Body, Stanton K. Shernan, Amanda A. Fox & Charles D. Collard. (2005) Pharmacogenetics of Anesthetic and Analgesic Agents. Anesthesiology 102:3, pages 663-671.
Crossref
Crossref
M Ingelman-Sundberg. (2004) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. The Pharmacogenomics Journal 5:1, pages 6-13.
Crossref
Crossref
B Pesch, T Brüning, R Frentzel-Beyme, G Johnen, V Harth, W Hoffmann, Y Ko, U Ranft, U.G Traugott, R Thier, D Taeger & H.M Bolt. (2004) Challenges to environmental toxicology and epidemiology: where do we stand and which way do we go?. Toxicology Letters 151:1, pages 255-266.
Crossref
Crossref
Nancy Price & Vinay K. Jain. (2004) Control of Chemotherapy-Induced Emesis with 5-Hydroxytryptamine-3 Antagonists. Supportive Cancer Therapy 1:3, pages 140-142.
Crossref
Crossref
J??rn L??tsch, Carsten Skarke, J??rgen Liefhold & Gerd Geisslinger. (2004) Genetic Predictors of the Clinical Response to Opioid Analgesics. Clinical Pharmacokinetics 43:14, pages 983-1013.
Crossref
Crossref
L. Madácsy, L. Barkai, A. Sánta & D. Krikovszky. (2004) Altered Distribution of the Debrisoquine Oxidative Phenotypes in Children with Type 1 Diabetes mellitus. Hormone Research in Paediatrics 61:4, pages 176-179.
Crossref
Crossref
David R Nelson, Darryl C Zeldin, Susan MG Hoffman, Lois J Maltais, Hester M Wain & Daniel W Nebert. (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1, pages 1-18.
Crossref
Crossref
James H. Doroshow & Timothy Synold. 2003. Thomas' Hematopoietic Cell Transplantation. Thomas' Hematopoietic Cell Transplantation
130
157
.
Elke Schaeffeler, Matthias Schwab, Michel Eichelbaum & Ulrich M. Zanger. (2003) CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-rime PCR. Human Mutation 22:6, pages 476-485.
Crossref
Crossref
Chun Xu, Shari Goodz, Edward M. Sellers & Rachel F. Tyndale. (2002) CYP2A6 genetic variation and potential consequences. Advanced Drug Delivery Reviews 54:10, pages 1245-1256.
Crossref
Crossref
Mikael Oscarson, Roman A. McLellan, Vendela Asp, MariCarmen Ledesma, Maria Luisa Bernal Ruiz, Blanca Sinues, Arja Rautio & Magnus Ingelman-Sundberg. (2002) Characterization of a novelCYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity. Human Mutation 20:4, pages 275-283.
Crossref
Crossref
Benedetta C. Sallustio, Ian S. Westley & Raymond G. Morris. (2002) Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady‐state dose. British Journal of Clinical Pharmacology 54:2, pages 107-114.
Crossref
Crossref
Eleni Aklillu, Karin Herrlin, Lars L Gustafsson, Leif Bertilsson & Magnus Ingelman-Sundberg. (2002) Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden. Pharmacogenetics 12:5, pages 375-383.
Crossref
Crossref
Magnus Ingelman-Sundberg. (2001) Genetic susceptibility to adverse effects of drugs and environmental toxicants. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 482:1-2, pages 11-19.
Crossref
Crossref
M. Ingelman‐Sundberg. (2001) Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy. Journal of Internal Medicine 250:3, pages 186-200.
Crossref
Crossref
Mercè Garcia-Barceló, Lok Yee Chow, Kwok Lim Lam, Helen Fung Kum Chiu, Yun Kowk Wing & Mary Miu Yee Waye. (2000) Occurrence of CYP2D6 Gene Duplication in Hong Kong Chinese. Clinical Chemistry 46:9, pages 1411-1413.
Crossref
Crossref
L. Laforest, H. Wikman, S. Benhamou, S.T. Saarikoski, C. Bouchardy, A. Hirvonen, P. Dayer & K. Husgafvel-Pursiainen. (2000) CYP2D6 gene polymorphism in Caucasian smokers. European Journal of Cancer 36:14, pages 1825-1832.
Crossref
Crossref
Sirkku Saarikoski, Fumihiro Sata, Kirsti Husgafvel-Pursiainen, Matti Rautalahti, Jari Haukka, Olli Impivaara, Jorma Jarvisalo, Harri Vainio & Ari Hirvonen. (2000) Pharmacogenetics 10:1, pages 5-10.
Crossref
Crossref